Market capitalization | $4.11b |
Enterprise Value | $5.46b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 32.13 |
EV/Sales (TTM) EV/Sales | 2.33 |
P/S ratio (TTM) P/S ratio | 1.76 |
P/B ratio (TTM) P/B ratio | 2.00 |
Revenue growth (TTM) Revenue growth | 3.99% |
Revenue (TTM) Revenue | $2.34b |
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
7 Analysts have issued a ICU Medical, Inc. forecast:
7 Analysts have issued a ICU Medical, Inc. forecast:
Sep '24 |
+/-
%
|
||
Revenue | 2,338 2,338 |
4%
4%
|
|
Gross Profit | 752 752 |
5%
5%
|
|
EBITDA | 258 258 |
50%
50%
|
EBIT (Operating Income) EBIT | 29 29 |
44%
44%
|
Net Profit | -111 -111 |
296%
296%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.
Head office | United States |
CEO | Vivek Jain |
Employees | 14,000 |
Founded | 1984 |
Website | www.icumed.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.